{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:22:51Z","timestamp":1792174971340,"version":"4.4.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Data on clinical manifestations of neurofibromatosis-Noonan syndrome (NF-NS) remain heterogeneous, with limited validated descriptions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study aims to better define the clinical and molecular features of NF-NS and compare them with existing literature. Secondary objectives include evaluating inter-rater diagnostic agreement among experienced clinicians and assessing the utility of deep-learning algorithms (Face2Gene<jats:sup>\u00ae<\/jats:sup> [F2G]). Additionally, we assess the prevalence of congenital heart malformations (CHM) in NF-NS compared to \u2018classic\u2019 neurofibromatosis type 1 (NF1). A 9-year, prospective, monocentric study was conducted, involving patients with <jats:italic>NF1<\/jats:italic> pathogenic variants (PVs) and Noonan syndrome-like facial phenotype (NSLFP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-six patients were enrolled. NSLFP was categorized as \u2018suggestive\u2019 in 69% of cases and \u2018typical\u2019 in 31%. The presence of at least two facial abnormalities (e.g., low-set ears, downslanted palpebral fissures, hypertelorism, and ptosis) was consistently observed in \u2018typical\u2019 cases. Inter-rater concordance was substantial (0.65 [95% CI\u2009=\u20090.56; 0.74]), while concordance between clinicians and F2G was almost perfect at (0.821 [CI 95% = 0.625; 1.000]). Missense <jats:italic>NF1<\/jats:italic> PVs were observed in 38.5% of cases. Apart from NSLP and a high frequency of pectus excavatum (62.5%), no significant differences in anthropometric, dermatological, neurological, skeletal, or ocular clinical features were observed between NF-NS and \u2018classic\u2019 NF1. CHM were found in 19.2% of NF-NS patients, with pulmonic stenosis present in 7.7%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>NF-NS is a distinct phenotypic variant of NF1, marked by NSLP with consistent facial features -, and frequent pectus excavatum. F2G demonstrated high diagnostic concordance, reinforcing its clinical utility. Given the elevated risk of CHM, especially pulmonic stenosis, proactive cardiovascular assessment similar to other RASopathies is recommended for NS-NF patients, regardless of <jats:italic>NF1<\/jats:italic> PV type.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03706-3","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T12:33:47Z","timestamp":1745757227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neurofibromatosis-Noonan syndrome: a prospective monocentric study of 26 patients and literature review"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3815-5417","authenticated-orcid":false,"given":"Didier","family":"Bessis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Vidaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5710-7376","authenticated-orcid":false,"given":"Pierre","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7969-0558","authenticated-orcid":false,"given":"Laurence","family":"Pacot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"de La Villeon","family":"G","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline Alice","family":"Bonnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6269-5966","authenticated-orcid":false,"given":"Yline","family":"Capri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Coubes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8358-5320","authenticated-orcid":false,"given":"Fanchon","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8956-2207","authenticated-orcid":false,"given":"Didier","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1786-0088","authenticated-orcid":false,"given":"Nicolas","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Poujade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Roubertie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1497-9363","authenticated-orcid":false,"given":"Julien","family":"Van Gils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Verloes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-6287","authenticated-orcid":false,"given":"David","family":"Genevi\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-1511","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Cav\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2959-0935","authenticated-orcid":false,"given":"Marjolaine","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,27]]},"reference":[{"key":"3706_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ajmg.1320210307","volume":"21","author":"JE Allanson","year":"1985","unstructured":"Allanson JE, Hall JG, Van Allen MI. Noonan phenotype associated with neurofibromatosis. Am J Med Genet. 1985;21:457\u201362.","journal-title":"Am J Med Genet"},{"key":"3706_CR2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/ajmg.1320290426","volume":"29","author":"DN Abuelo","year":"1988","unstructured":"Abuelo DN, Meryash DL. Neurofibromatosis with fully expressed Noonan syndrome. Am J Med Genet. 1988;29:937\u201341.","journal-title":"Am J Med Genet"},{"key":"3706_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/(SICI)1096-8628(19961218)66:3<347::AID-AJMG20>3.0.CO;2-L","volume":"66","author":"M Bahuau","year":"1996","unstructured":"Bahuau M, Flintoff W, Assouline B, Lyonnet S, Le Merrer M, Prieur M, et al. Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association. Am J Med Genet. 1996;66:347\u201355.","journal-title":"Am J Med Genet"},{"key":"3706_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/(SICI)1096-8628(19980123)75:3<265::AID-AJMG8>3.0.CO;2-P","volume":"75","author":"M Bahuau","year":"1998","unstructured":"Bahuau M, Houdayer C, Assouline B, Blanchet-Bardon C, Le Merrer M, Lyonnet S, et al. Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome. Am J Med Genet. 1998;75:265\u201372.","journal-title":"Am J Med Genet"},{"key":"3706_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12887-019-1463-1","volume":"19","author":"I Baquedano Lobera","year":"2019","unstructured":"Baquedano Lobera I, Izquierdo \u00c1lvarez S, Oliv\u00e1n D, Cacho MJ. Rasopathies case report: concurrence of two pathogenic variations de Novo in NF1 and KRAS genes in a patient. BMC Pediatr. 2019;19:92.","journal-title":"BMC Pediatr"},{"key":"3706_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.20023","volume":"119A","author":"D Baralle","year":"2003","unstructured":"Baralle D, Mattocks C, Kalidas K, Elmslie F, Whittaker J, Lees M, et al. Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS). Am J Med Genet A. 2003;119A:1\u20138.","journal-title":"Am J Med Genet A"},{"key":"3706_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ejhg.2012.221","volume":"21","author":"S Ben-Shachar","year":"2013","unstructured":"Ben-Shachar S, Constantini S, Hallevi H, Sach EK, Upadhyaya M, Evans GD, Huson SM. Increased rate of missense\/in-frame mutations in individuals with NF1-related pulmonic stenosis: a novel genotype-phenotype correlation. Eur J Hum Genet. 2013;21:535\u20139.","journal-title":"Eur J Hum Genet"},{"key":"3706_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ajmg.a.30813","volume":"136","author":"DR Bertola","year":"2005","unstructured":"Bertola DR, Pereira AC, Passetti F, de Oliveira PS, Messiaen L, Gelb BD, et al. Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient. Am J Med Genet A. 2005;136:242\u20135.","journal-title":"Am J Med Genet A"},{"key":"3706_CR9","first-page":"309","volume":"2","author":"Z Borochowitz","year":"1989","unstructured":"Borochowitz Z, Berant N, Dar H, Berant M. The neurofibromatosis-Noonan syndrome: genetic heterogeneity versus clinical variability. Case report and review of the literature. Neurofibromatosis. 1989;2:309\u201314.","journal-title":"Neurofibromatosis"},{"key":"3706_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1525-1470.1995.tb00175.x","volume":"12","author":"L Buehning","year":"1995","unstructured":"Buehning L, Curry CJ. Neurofibromatosis-Noonan syndrome. Pediatr Dermatol. 1995;12:267\u201371.","journal-title":"Pediatr Dermatol"},{"key":"3706_CR11","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1136\/jmg.40.10.e109","volume":"40","author":"B Castle","year":"2003","unstructured":"Castle B, Baser ME, Huson SM, Cooper DN, Upadhyaya M. Evaluation of genotype-phenotype correlations in neurofibromatosis type 1. J Med Genet. 2003;40:e109.","journal-title":"J Med Genet"},{"key":"3706_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1399-0004.1996.tb04328.x","volume":"49","author":"A Colley","year":"1996","unstructured":"Colley A, Donnai D, Evans DG. Neurofibromatosis\/Noonan phenotype: a variable feature of type 1 neurofibromatosis. Clin Genet. 1996;49:59\u201364.","journal-title":"Clin Genet"},{"key":"3706_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MCD.0b013e3283557231","volume":"21","author":"EA Croonen","year":"2012","unstructured":"Croonen EA, Yntema HG, van Minkelen R, van den Ouweland AMW, van der Burgt I. Patient with a neurofibromatosis type 1 mutation but a clinical diagnosis of Noonan syndrome. Clin Dysmorphol. 2012;21:212\u20134.","journal-title":"Clin Dysmorphol"},{"key":"3706_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/cge.14040","volume":"100","author":"A D\u2019Amico","year":"2021","unstructured":"D\u2019Amico A, Rosano C, Pannone L, Pinna V, Assunto A, et al. Clinical variability of neurofibromatosis 1: A modifying role of cooccurring PTPN11 variants and atypical brain MRI findings. Clin Genet. 2021;100:563\u201372.","journal-title":"Clin Genet"},{"key":"3706_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40246-023-00460-0","volume":"17","author":"S Dalili","year":"2023","unstructured":"Dalili S, Hoseini Nouri SA, Bayat R, Koohmanaee S, Tabrizi M, et al. Neurofibromatosis-Noonan syndrome and growth deficiency in an Iranian Girl due to a pathogenic variant in NF1 gene. Hum Genomics. 2023;17:12.","journal-title":"Hum Genomics"},{"key":"3706_CR16","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1086\/498454","volume":"77","author":"A De Luca","year":"2005","unstructured":"De Luca A, Bottillo I, Sarkozy A, Carta C, Neri C, Bellacchio E, et al. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. Am J Hum Genet. 2005;77:1092\u2013101.","journal-title":"Am J Hum Genet"},{"key":"3706_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/ajmg.a.36313","volume":"164A","author":"S Ekvall","year":"2014","unstructured":"Ekvall S, Sj\u00f6rs K, Jonzon A, Vihinen M, Anner\u00e9n G, Bondeson ML. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome. Am J Med Genet A. 2014;164A:579\u201387.","journal-title":"Am J Med Genet A"},{"key":"3706_CR18","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1002\/ajmg.a.31547","volume":"140","author":"U H\u00fcffmeier","year":"2006","unstructured":"H\u00fcffmeier U, Zenker M, Hoyer J, Fahsold R, Rauch A. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene. Am J Med Genet A. 2006;140:2749\u201356.","journal-title":"Am J Med Genet A"},{"key":"3706_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4274\/jcrpe.galenos.2019.2019.0023","volume":"12","author":"E I\u015f\u0131k","year":"2020","unstructured":"I\u015f\u0131k E, Onay H, Atik T, Solmaz AE, \u00d6zen S, \u00c7o\u011fulu \u00d6, et al. A neurofibromatosis Noonan syndrome patient presenting with abnormal external genitalia. J Clin Res Pediatr Endocrinol. 2020;12:113\u20136.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"3706_CR20","first-page":"424","volume":"54","author":"LM Kayes","year":"1994","unstructured":"Kayes LM, Burke W, Riccardi VM, Bennett R, Ehrlich P, Rubenstein A, Stephens K. Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet. 1994;54:424\u201336.","journal-title":"Am J Hum Genet"},{"key":"3706_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ajmg.1320210308","volume":"21","author":"P Kaplan","year":"1985","unstructured":"Kaplan P, Rosenblatt B. A distinctive facial appearance in neurofibromatosis von Recklinghausen. Am J Med Genet. 1985;21:463\u201370.","journal-title":"Am J Med Genet"},{"key":"3706_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","volume":"102","author":"M Koczkowska","year":"2018","unstructured":"Koczkowska M, Chen Y, Callens T, Gomes A, Sharp A, Johnson S, et al. Genotype-Phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844\u2013848. Am J Hum Genet. 2018;102:69\u201387.","journal-title":"Am J Hum Genet"},{"key":"3706_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41436-018-0269-0","volume":"21","author":"M Koczkowska","year":"2019","unstructured":"Koczkowska M, Callens T, Gomes A, Sharp A, Chen Y, Hicks AD, et al. Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation. Genet Med. 2019;21:867\u201376.","journal-title":"Genet Med"},{"key":"3706_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/humu.23929","volume":"41","author":"M Koczkowska","year":"2020","unstructured":"Koczkowska M, Callens T, Chen Y, Gomes A, Hicks AD, Sharp A, et al. Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1. Hum Mutat. 2020;41:299\u2013315.","journal-title":"Hum Mutat"},{"key":"3706_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ajmg.1320260331","volume":"26","author":"P Meinecke","year":"1987","unstructured":"Meinecke P. Evidence that the neurofibromatosis-Noonan syndrome is a variant of von Recklinghausen neurofibromatosis. Am J Med Genet. 1987;26:741\u20135.","journal-title":"Am J Med Genet"},{"key":"3706_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ajmg.1320210309","volume":"21","author":"HM Mendez","year":"1985","unstructured":"Mendez HM. The neurofibromatosis-Noonan syndrome. Am J Med Genet. 1985;21:471\u20136.","journal-title":"Am J Med Genet"},{"key":"3706_CR27","first-page":"e42098","volume":"15","author":"I Mohapatra","year":"2023","unstructured":"Mohapatra I, Samantaray SR. Neurofibromatosis-Noonan syndrome with primary amenorrhoea: A case report. Cureus. 2023;15:e42098.","journal-title":"Cureus"},{"key":"3706_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1399-0004.2009.01233.x","volume":"76","author":"AM Nystr\u00f6m","year":"2009","unstructured":"Nystr\u00f6m AM, Ekvall S, Allanson J, Edeby C, Elinder M, Holmstr\u00f6m G, et al. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1. Clin Genet. 2009;76:524\u201334.","journal-title":"Clin Genet"},{"key":"3706_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1651-2227.2008.01170.x","volume":"98","author":"AM Nystr\u00f6m","year":"2009","unstructured":"Nystr\u00f6m AM, Ekvall S, Str\u00f6mberg B, Holmstr\u00f6m G, Thuresson AC, Anner\u00e9n G, Bondeson ML. A severe form of Noonan syndrome and autosomal dominant caf\u00e9-au-lait spots - evidence for different genetic origins. Acta Paediatr. 2009;98:693\u20138.","journal-title":"Acta Paediatr"},{"key":"3706_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ajmg.1320210310","volume":"21","author":"JM Opitz","year":"1985","unstructured":"Opitz JM, Weaver DD. The neurofibromatosis-Noonan syndrome. Am J Med Genet. 1985;21:477\u201390.","journal-title":"Am J Med Genet"},{"key":"3706_CR31","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/ejhg.2014.243","volume":"23","author":"V Pinna","year":"2015","unstructured":"Pinna V, Lanari V, Daniele P, Consoli F, Agolini E, Margiotti K, et al. p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Eur J Hum Genet. 2015;23:1068\u201371.","journal-title":"Eur J Hum Genet"},{"key":"3706_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/genes10090675","volume":"10","author":"V Pinna","year":"2019","unstructured":"Pinna V, Daniele P, Calcagni G, Mariniello L, Criscione R, Giardina C, et al. Prevalence, type, and molecular spectrum of NF1 mutations in patients with neurofibromatosis type 1 and congenital heart disease. Genes (Basel). 2019;10:675.","journal-title":"Genes (Basel)"},{"key":"3706_CR33","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/ajmg.a.33996","volume":"155A","author":"CE Prada","year":"2011","unstructured":"Prada CE, Zarate YA, Hagenbuch S, Lovell A, Schorry EK, Hopkin RJ. Lethal presentation of neurofibromatosis and Noonan syndrome. Am J Med Genet A. 2011;155A:1360\u20136.","journal-title":"Am J Med Genet A"},{"key":"3706_CR34","doi-asserted-by":"publisher","first-page":"438","DOI":"10.4274\/jcrpe.galenos.2022.2021-12-24","volume":"15","author":"S Qin","year":"2023","unstructured":"Qin S, Zhang Y, Yu F, Ni Y, Zhong J. A novel heterozygous NF1 variant in a Neurofibromatosis-Noonan syndrome patient with growth hormone deficiency: A case report. J Clin Res Pediatr Endocrinol. 2023;15:438\u201343.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"3706_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ajmg.1320260320","volume":"26","author":"T Quattrin","year":"1987","unstructured":"Quattrin T, McPherson E, Putnam T. Vertical transmission of the neurofibromatosis\/noonan syndrome. Am J Med Genet. 1987;26:645\u20139.","journal-title":"Am J Med Genet"},{"key":"3706_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5070\/D329S5592H","volume":"17","author":"I Reig","year":"2011","unstructured":"Reig I, Boixeda P, Fleta B, Morenoc C, G\u00e1mez L, Truchuelo M. Neurofibromatosis-Noonan syndrome: case report and clinicopathogenic review of the Neurofibromatosis-Noonan syndrome and RAS-MAPK pathway. Dermatol Online J. 2011;17:4.","journal-title":"Dermatol Online J"},{"key":"3706_CR37","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/humu.22832","volume":"36","author":"K Rojnueangnit","year":"2015","unstructured":"Rojnueangnit K, Xie J, Gomes A, Sharp A, Callens T, Chen Y, et al. High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: Genotype-Phenotype correlation. Hum Mutat. 2015;36:1052\u201363.","journal-title":"Hum Mutat"},{"key":"3706_CR38","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ejhg.2015.93","volume":"23","author":"C Santoro","year":"2015","unstructured":"Santoro C, Maietta A, Giugliano T, Melis D, Perrotta S, Nigro V, Piluso G. Arg(1809) substitution in neurofibromin: further evidence of a genotype-phenotype correlation in neurofibromatosis type 1. Eur J Hum Genet. 2015;23:1460\u20131.","journal-title":"Eur J Hum Genet"},{"key":"3706_CR39","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ajmg.1320210311","volume":"21","author":"RA Saul","year":"1985","unstructured":"Saul RA. Noonan syndrome in a patient with hyperplasia of the myenteric plexuses and neurofibromatosis. Am J Med Genet. 1985;21:491\u20132.","journal-title":"Am J Med Genet"},{"key":"3706_CR40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/adc.62.2.196","volume":"62","author":"A Shuper","year":"1987","unstructured":"Shuper A, Mukamel M, Mimouni M, Steinherz R. Noonan\u2019s syndrome and neurofibromatosis. Arch Dis Child. 1987;62:196\u20138.","journal-title":"Arch Dis Child"},{"key":"3706_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/jmg.29.3.184","volume":"29","author":"HJ Stern","year":"1992","unstructured":"Stern HJ, Saal HM, Lee JS, Fain PR, Goldgar DE, Rosenbaum KN, Barker DF. Clinical variability of type 1 neurofibromatosis: is there a neurofibromatosis-Noonan syndrome? J Med Genet. 1992;29:184\u20137.","journal-title":"J Med Genet"},{"key":"3706_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1399-0004.2006.00576.x","volume":"69","author":"DA Stevenson","year":"2006","unstructured":"Stevenson DA, Viskochil DH, Rope AF, Carey JC. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype. Clin Genet. 2006;69:246\u201353.","journal-title":"Clin Genet"},{"key":"3706_CR43","first-page":"90","volume":"53","author":"M Tassabehji","year":"1993","unstructured":"Tassabehji M, Strachan T, Sharland M, Colley A, Donnai D, Harris R, Thakker N. Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet. 1993;53:90\u20135.","journal-title":"Am J Hum Genet"},{"key":"3706_CR44","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/ajmg.a.32837","volume":"149A","author":"C Thiel","year":"2009","unstructured":"Thiel C, Wilken M, Zenker M, Sticht H, Fahsold R, Gusek-Schneider GC, Rauch A. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome. Am J Med Genet A. 2009;149A:1263\u20137.","journal-title":"Am J Med Genet A"},{"key":"3706_CR45","doi-asserted-by":"publisher","first-page":"e616","DOI":"10.1002\/mgg3.616","volume":"7","author":"E Trevisson","year":"2019","unstructured":"Trevisson E, Morbidoni V, Forzan M, Daolio C, Fumini V, Parrozzani R, et al. The Arg1038Gly missense variant in the NF1 gene causes a mild phenotype without neurofibromas. Mol Genet Genomic Med. 2019;7:e616.","journal-title":"Mol Genet Genomic Med"},{"key":"3706_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1086\/510781","volume":"80","author":"M Upadhyaya","year":"2007","unstructured":"Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, et al. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970\u20132972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet. 2007;80:140\u201351.","journal-title":"Am J Hum Genet"},{"key":"3706_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4274\/jcrpe.2070","volume":"8","author":"D Vurall\u0131","year":"2016","unstructured":"Vurall\u0131 D, G\u00f6n\u00e7 N, Vidaud D, \u00d6z\u00f6n A, Alika\u015fifo\u011flu A, Kandemir N. Growth hormone deficiency in a child with Neurofibromatosis-Noonan syndrome. J Clin Res Pediatr Endocrinol. 2016;8:96\u2013100.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"3706_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/(SICI)1098-1004(1996)8:1<51::AID-HUMU7>3.0.CO;2-S","volume":"8","author":"R Wu","year":"1996","unstructured":"Wu R, Legius E, Robberecht W, Dumoulin M, Cassiman JJ, Fryns JP. Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome. Hum Mutat. 1996;8:51\u20136.","journal-title":"Hum Mutat"},{"key":"3706_CR49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.21873\/invivo.11015","volume":"30","author":"C Yapijakis","year":"2016","unstructured":"Yapijakis C, Pachis N, Natsis S, Voumvourakis C. Is neurofibromatosis type 1-Noonan syndrome a phenotypic result of combined genetic and epigenetic factors?? Vivo. 2016;30:315\u201320.","journal-title":"Vivo"},{"key":"3706_CR50","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tripleo.2003.12.042","volume":"98","author":"M Yazdizadeh","year":"2004","unstructured":"Yazdizadeh M, Tapia JL, Baharvand M, Radfar L. A case of neurofibromatosis-Noonan syndrome with a central giant cell granuloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:316\u201320.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"3706_CR51","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s00381-012-1905-7","volume":"28","author":"S Yimenicio\u011flu","year":"2012","unstructured":"Yimenicio\u011flu S, Yakut A, Karaer K, Zenker M, Ekici A, Carman KB. A new nonsense mutation in the NF1 gene with neurofibromatosis-Noonan syndrome phenotype. Childs Nerv Syst. 2012;28:2181\u20133.","journal-title":"Childs Nerv Syst"},{"key":"3706_CR52","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12887-020-02102-z","volume":"20","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Chen X, Zhou R, Yin H, Xu J. Chinese patient with neurofibromatosis-Noonan syndrome caused by novel heterozygous NF1 exons 1\u201358 deletion: a case report. BMC Pediatr. 2020;20:190.","journal-title":"BMC Pediatr"},{"key":"3706_CR53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","volume":"381","author":"AE Roberts","year":"2013","unstructured":"Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet. 2013;381:333\u201342.","journal-title":"Lancet"},{"key":"3706_CR54","doi-asserted-by":"publisher","first-page":"e1149","DOI":"10.1542\/peds.2013-3189","volume":"134","author":"ME Pierpont","year":"2014","unstructured":"Pierpont ME, Magoulas PL, Adi S, Kavamura MI, Neri G, Noonan J, et al. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2014;134:e1149\u201362.","journal-title":"Pediatrics"},{"key":"3706_CR55","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/ajmg.a.61270","volume":"179","author":"KW Gripp","year":"2019","unstructured":"Gripp KW, Morse LA, Axelrad M, Chatfield KC, Chidekel A, Dobyns W, et al. Costello syndrome: clinical phenotype, genotype, and management guidelines. Am J Med Genet A. 2019;179:1725\u201344.","journal-title":"Am J Med Genet A"},{"key":"3706_CR56","doi-asserted-by":"crossref","unstructured":"Neurofibromatosis conference statement. National Institutes of Health Consensus Development Conference. Arch. Neurol. 1988;45:575\u20138.","DOI":"10.1001\/archneur.1988.00520290115023"},{"key":"3706_CR57","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, et al. Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med. 2021;23:1506\u201313.","journal-title":"Genet Med"},{"key":"3706_CR58","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/ajmg.a.62092","volume":"185","author":"A Marwaha","year":"2021","unstructured":"Marwaha A, Chitayat D, Meyn MS, Mendoza-Londono R, Chad L. The point-of-care use of a facial phenotyping tool in the genetics clinic: enhancing diagnosis and education with machine learning. Am J Med Genet A. 2021;185:1151\u20138.","journal-title":"Am J Med Genet A"},{"key":"3706_CR59","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/humu.23624","volume":"39","author":"AR Grant","year":"2018","unstructured":"Grant AR, Cushman BJ, Cav\u00e9 H, Dillon MW, Gelb BD, Gripp KW, et al. Assessing the gene-disease association of 19 genes with the rasopathies using the ClinGen gene curation framework. Hum Mutat. 2018;39:1485\u201393.","journal-title":"Hum Mutat"},{"key":"3706_CR60","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"3706_CR61","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/gim.2018.3","volume":"20","author":"BD Gelb","year":"2018","unstructured":"Gelb BD, Cav\u00e9 H, Dillon MW, Gripp KW, Lee JA, Mason-Suares H, et al. Genet Med. 2018;20:1334\u201345.","journal-title":"Genet Med"},{"key":"3706_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1172-2-4","volume":"2","author":"I van der Burgt","year":"2007","unstructured":"van der Burgt I. Noonan syndrome. Orphanet J Rare Dis. 2007;2:4.","journal-title":"Orphanet J Rare Dis"},{"key":"3706_CR63","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jpeds.2003.11.032","volume":"144","author":"M Zenker","year":"2004","unstructured":"Zenker M, Buheitel G, Rauch R, Koenig R, Bosse K, Kress W, et al. Genotype-phenotype correlations in Noonan syndrome. J Pediatr. 2004;144:368\u201374.","journal-title":"J Pediatr"},{"key":"3706_CR64","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U","volume":"70","author":"JM Friedman","year":"1997","unstructured":"Friedman JM, Birch PH. Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet. 1997;70:138\u201343.","journal-title":"Am J Med Genet"},{"key":"3706_CR65","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/088307380201700812","volume":"17","author":"H Young","year":"2002","unstructured":"Young H, Hyman S, North K. Neurofibromatosis: clinical review and exceptions to the rules. J Child Neurol. 2002;17:613\u201321.","journal-title":"J Child Neurol"},{"key":"3706_CR66","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1001\/archderm.139.2.187","volume":"139","author":"K Khosrotehrani","year":"2003","unstructured":"Khosrotehrani K, Bastuji-Garin S, Zeller J, Revuz J, Wolkenstein P. Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients. Arch Dermatol. 2003;139:187\u201391.","journal-title":"Arch Dermatol"},{"key":"3706_CR67","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/ajmg.c.32015","volume":"190","author":"M Zenker","year":"2022","unstructured":"Zenker M. Clinical overview on rasopathies. Am J Med Genet C Semin Med Genet. 2022;190:414\u201324.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"3706_CR68","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1111\/bjd.17404","volume":"180","author":"D Bessis","year":"2019","unstructured":"Bessis D, Miquel J, Bourrat E, Chiaverini C, Morice-Picard F, Abadie C, et al. Dermatological manifestations in Noonan syndrome: a prospective multicentric study of 129 patients positive for mutation. Br J Dermatol. 2019;180:1438\u201348.","journal-title":"Br J Dermatol"},{"key":"3706_CR69","doi-asserted-by":"crossref","unstructured":"Mastromoro G, Santoro C, Motta M, Sorrentino U, Daniele P, Peduto C, et al. Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple cafe-au-lait macules. Genet Med. 2024 Aug;10:101241.","DOI":"10.1016\/j.gim.2024.101241"},{"key":"3706_CR70","doi-asserted-by":"crossref","unstructured":"Matthews H, Vanneste M, Katsura K, Aponte D, Patton M, Hammond P, et al. Refining nosology by modelling variation among facial phenotypes: the rasopathies. J Med Genet. 2022 Jul;20:jmedgenet\u20132021.","DOI":"10.1136\/jmedgenet-2021-108366"},{"key":"3706_CR71","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","volume":"111","author":"SM Huson","year":"1988","unstructured":"Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain. 1988;111:1355\u201381.","journal-title":"Brain"},{"key":"3706_CR72","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/jmg.35.8.624","volume":"35","author":"MH Cnossen","year":"1998","unstructured":"Cnossen MH, Moons KG, Garssen MP, Pasmans NM, de Goede-Bolder A, Niermeijer MF, Grobbee DE. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children\u2009<\u2009or =\u20096 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia children\u2019s hospital. J Med Genet. 1998;35:624\u20137.","journal-title":"J Med Genet"},{"key":"3706_CR73","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s10038-019-0695-0","volume":"65","author":"E Kang","year":"2020","unstructured":"Kang E, Kim YM, Seo GH, Oh A, Yoon HM, Ra YS, et al. Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types. J Hum Genet. 2020;65:79\u201389.","journal-title":"J Hum Genet"},{"key":"3706_CR74","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s13023-022-02482-8","volume":"17","author":"DL Basto","year":"2022","unstructured":"Basto DL, de Souza Vieira G, Andrade-Losso RM, Almeida PN, Riccardi VM, Rozza-de-Menezes RE, et al. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and Familial neurofibromatosis 1 Brazilian adults: a cross-sectional study. Orphanet J Rare Dis. 2022;17:341.","journal-title":"Orphanet J Rare Dis"},{"key":"3706_CR75","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2147\/JMDH.S454921","volume":"17","author":"M Almuqbil","year":"2024","unstructured":"Almuqbil M, Alshaikh FY, Altwaijri W, Baarmah D, Hommady RH, Alshaikh MY, et al. Epidemiology and outcomes of neurofibromatosis type 1 (NF-1): multicenter tertiary experience. J Multidiscip Healthc. 2024;17:1303\u201314.","journal-title":"J Multidiscip Healthc"},{"issue":"Suppl 1","key":"3706_CR76","first-page":"88","volume":"156","author":"E Miraglia","year":"2021","unstructured":"Miraglia E, Chello C, Calvieri S, Giustini S. Pectus excavatum in neurofibromatosis type 1: a single-center experience. Ital J Dermatol Venerol. 2021;156(Suppl 1):88\u20139.","journal-title":"Ital J Dermatol Venerol"},{"key":"3706_CR77","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0","volume":"95","author":"AE Lin","year":"2000","unstructured":"Lin AE, Birch PH, Korf BR, Tenconi R, Niimura M, Poyhonen M, et al. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet. 2000;95:108\u201317.","journal-title":"Am J Med Genet"},{"key":"3706_CR78","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00467-003-1397-5","volume":"19","author":"G Lama","year":"2004","unstructured":"Lama G, Graziano L, Calabrese E, Grassia C, Rambaldi PF, Cioce F, et al. Blood pressure and cardiovascular involvement in children with neurofibromatosis type1. Pediatr Nephrol. 2004;19:413\u20138.","journal-title":"Pediatr Nephrol"},{"key":"3706_CR79","first-page":"714","volume":"43","author":"F \u0130ncecik","year":"2015","unstructured":"\u0130ncecik F, Herg\u00fcner \u00d6M, Al\u0131n\u00e7 Erdem S, Altunba\u015fak \u015e. Neurofibromatosis type 1 and cardiac manifestations. Turk Kardiyol Dern Ars. 2015;43:714\u20136.","journal-title":"Turk Kardiyol Dern Ars"},{"key":"3706_CR80","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13023-017-0756-4","volume":"13","author":"J Lepp\u00e4virta","year":"2018","unstructured":"Lepp\u00e4virta J, Kallionp\u00e4\u00e4 RA, Uusitalo E, Vahlberg T, P\u00f6yh\u00f6nen M, Peltonen J, Peltonen S. Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study. Orphanet J Rare Dis. 2018;13:5.","journal-title":"Orphanet J Rare Dis"},{"key":"3706_CR81","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1067\/mhj.2002.122121","volume":"143","author":"MA Tedesco","year":"2002","unstructured":"Tedesco MA, Di Salvo G, Natale F, Pergola V, Calabrese E, Grassia C, et al. The heart in neurofibromatosis type 1: an echocardiographic study. Am Heart J. 2002;143:883\u20138.","journal-title":"Am Heart J"},{"key":"3706_CR82","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/ajmg.a.37736","volume":"170","author":"JE Allanson","year":"2016","unstructured":"Allanson JE. Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras\/MAPK signaling pathway. Am J Med Genet A. 2016;170:2570\u20137.","journal-title":"Am J Med Genet A"},{"key":"3706_CR83","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1001\/archderm.1984.01650480041014","volume":"120","author":"W Westerhof","year":"1984","unstructured":"Westerhof W, Delleman JW, Wolters E, Dijkstra P. Neurofibromatosis and hypertelorism. Arch Dermatol. 1984;120:1579\u201381.","journal-title":"Arch Dermatol"},{"key":"3706_CR84","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/ajmg.1320250323","volume":"25","author":"BD Hall","year":"1986","unstructured":"Hall BD. Congenital lid ptosis associated with neurofibromatosis. Am J Med Genet. 1986;25:595\u20137.","journal-title":"Am J Med Genet"},{"key":"3706_CR85","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.1038\/s41598-023-33374-x","volume":"13","author":"LM Echeverry-Quiceno","year":"2023","unstructured":"Echeverry-Quiceno LM, Candelo E, G\u00f3mez, Sol\u00eds P, Ram\u00edrez D, Ortiz D, et al. Population-specific facial traits and diagnosis accuracy of genetic and rare diseases in an admixed Colombian population. Sci Rep. 2023;13:6869. https:\/\/doi.org\/10.1038\/s41598-023-33374-x.","journal-title":"Sci Rep"},{"key":"3706_CR86","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00125817-200205000-00002","volume":"4","author":"JM Friedman","year":"2002","unstructured":"Friedman JM, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, Lin AE, et al. Cardiovascular disease in neurofibromatosis 1: report of the NF1 cardiovascular task force. Genet Med. 2002;4:105\u201311.","journal-title":"Genet Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03706-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03706-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03706-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T14:02:21Z","timestamp":1745762541000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03706-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3706"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03706-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,27]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patients in this manuscript have given written informed consent for publication of their case details. This.work was approved by the clinical research department of the university hospital of the principal investigator.(D.B), the Consultative Committee for the Processing of Health Research Data (CCTIRS; 12.750) and the National.Commission on Informatics and Liberty (CNIL; 913041).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients in this manuscript have given written informed consent for publication of their case details.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest regarding this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work was approved by the clinical research department of the university hospital of the principal investigator (D.B), the Consultative Committee for the Processing of Health Research Data (CCTIRS; 12.750) and the National Commission on Informatics and Liberty (CNIL; 913041).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}